EG20476A - Process for preparing of n,n'- substituted imidodicarboninidic diamides derived from hydroxylamines - Google Patents

Process for preparing of n,n'- substituted imidodicarboninidic diamides derived from hydroxylamines

Info

Publication number
EG20476A
EG20476A EG7993A EG7993A EG20476A EG 20476 A EG20476 A EG 20476A EG 7993 A EG7993 A EG 7993A EG 7993 A EG7993 A EG 7993A EG 20476 A EG20476 A EG 20476A
Authority
EG
Egypt
Prior art keywords
group
carbon atoms
mono
substituted
salts
Prior art date
Application number
EG7993A
Other languages
English (en)
Original Assignee
Jacobus Pharma Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jacobus Pharma Co Inc filed Critical Jacobus Pharma Co Inc
Application granted granted Critical
Publication of EG20476A publication Critical patent/EG20476A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/20Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups containing any of the groups, X being a hetero atom, Y being any atom, e.g. acylguanidines
    • C07C279/24Y being a hetero atom
    • C07C279/26X and Y being nitrogen atoms, i.e. biguanides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06Antimalarials
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/10Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C323/11Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/13Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being saturated and containing rings
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Paints Or Removers (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Detergent Compositions (AREA)
  • Luminescent Compositions (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Seasonings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
EG7993A 1992-02-14 1993-02-11 Process for preparing of n,n'- substituted imidodicarboninidic diamides derived from hydroxylamines EG20476A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/837,258 US5322858A (en) 1992-02-14 1992-02-14 N,N'-substituted imidodicarbonimidic diamides derived from hydroxylamines

Publications (1)

Publication Number Publication Date
EG20476A true EG20476A (en) 1999-05-31

Family

ID=25273975

Family Applications (1)

Application Number Title Priority Date Filing Date
EG7993A EG20476A (en) 1992-02-14 1993-02-11 Process for preparing of n,n'- substituted imidodicarboninidic diamides derived from hydroxylamines

Country Status (25)

Country Link
US (1) US5322858A (zh)
EP (1) EP0625967B1 (zh)
JP (1) JP3207200B2 (zh)
KR (1) KR950700243A (zh)
CN (1) CN1057520C (zh)
AT (1) ATE157352T1 (zh)
AU (1) AU668709B2 (zh)
CA (1) CA2129430C (zh)
CZ (1) CZ294257B6 (zh)
DE (1) DE69313438T2 (zh)
DK (1) DK0625967T3 (zh)
EG (1) EG20476A (zh)
ES (1) ES2108862T3 (zh)
FI (1) FI943738A (zh)
GR (1) GR3025429T3 (zh)
HU (1) HU220389B (zh)
IL (1) IL104484A (zh)
MX (1) MX9300688A (zh)
NO (1) NO302616B1 (zh)
NZ (1) NZ245865A (zh)
OA (1) OA10094A (zh)
PL (2) PL172001B1 (zh)
RU (1) RU2133737C1 (zh)
WO (1) WO1993016037A1 (zh)
ZA (1) ZA93974B (zh)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4321444A1 (de) * 1993-06-28 1995-01-05 Bernd Prof Dr Clement Pharmazeutische Zubereitung
US6551614B2 (en) 2001-03-14 2003-04-22 Jacobus Pharmaceutical Co., Inc. Antimalarial N,N′-substituted biguanides derived from hydroxylamines
AU2003220222A1 (en) 2002-03-13 2003-09-29 Signum Biosciences, Inc. Modulation of protein methylation and phosphoprotein phosphate
US7256218B2 (en) * 2002-11-22 2007-08-14 Jacobus Pharmaceutical Company, Inc. Biguanide and dihydrotriazine derivatives
CN1738794B (zh) * 2002-11-22 2010-12-22 雅各布斯制药公司 双胍和二氢三嗪衍生物
WO2006084033A1 (en) * 2005-02-03 2006-08-10 Signum Biosciences, Inc. Compositions and methods for enhancing cognitive function
US7923041B2 (en) 2005-02-03 2011-04-12 Signum Biosciences, Inc. Compositions and methods for enhancing cognitive function
KR101578949B1 (ko) 2007-10-08 2015-12-18 엠엠브이 메디슨즈 포 말라리아 벤처 가요성 측쇄를 가지는 항말라리아 화합물
MX2010003972A (es) * 2007-10-13 2010-08-09 Univ Cornell Composiciones para producir una respuesta inmune contra para-tuberculosis sub-especie mycobacterium avium.
EP2282735B1 (en) 2008-04-21 2019-01-16 Signum Biosciences, Inc. Pp2a modulators for treating alzheimer, parkinson, diabetes
EP2273974A2 (en) * 2008-05-09 2011-01-19 Tolmar, Inc. Proguanil to treat skin/mucosal diseases
US10829440B2 (en) 2015-06-12 2020-11-10 Brown University Antibacterial compounds and methods of making and using same
WO2018106907A1 (en) * 2016-12-08 2018-06-14 Novatarg, Inc. Fused bicyclic alkylene linked imidodicarbonimidic diamides, methods for synthesis, and uses in therary
US11555010B2 (en) 2019-07-25 2023-01-17 Brown University Diamide antimicrobial agents

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB603070A (en) * 1946-01-25 1948-06-08 Albert Frederick Crowther Manufacture of biguanide derivatives
GB665680A (en) * 1948-02-20 1952-01-30 Rhone Poulenc Sa Improvements in or relating to the production of n-p-chlorophenyl-n-isopropyl biguanide
DE824942C (de) * 1949-01-31 1951-12-17 Ici Ltd Verfahren zur Herstellung von Biguanidderivaten
GB667116A (en) * 1949-04-25 1952-02-27 Albert Frederick Crowther Manufacture of biguanide derivatives
GB814563A (en) * 1956-11-15 1959-06-10 Vitamins Ltd Biguanides
GB1270831A (en) * 1968-11-22 1972-04-19 Beecham Group Ltd Di-hydro triazine derivatives and processes for their manufacture
GB1250531A (zh) * 1969-01-01 1971-10-20
US3723429A (en) * 1969-11-06 1973-03-27 Beecham Group Ltd Di-hydro triazine derivatives
US3660394A (en) * 1970-01-23 1972-05-02 Vitamins Ltd 4 6-dibenzo-1 2-dihydro-aryloxy-1 3 5-triazines

Also Published As

Publication number Publication date
CN1076689A (zh) 1993-09-29
JPH07503730A (ja) 1995-04-20
HUT68802A (en) 1995-07-28
CA2129430A1 (en) 1993-08-15
MX9300688A (es) 1993-08-01
ATE157352T1 (de) 1997-09-15
ZA93974B (en) 1993-09-14
HU220389B (hu) 2002-01-28
DE69313438D1 (de) 1997-10-02
KR950700243A (ko) 1995-01-16
CA2129430C (en) 2004-04-06
NZ245865A (en) 1996-02-27
JP3207200B2 (ja) 2001-09-10
PL172001B1 (pl) 1997-07-31
ES2108862T3 (es) 1998-01-01
FI943738A0 (fi) 1994-08-12
US5322858A (en) 1994-06-21
CZ196494A3 (en) 1995-10-18
PL173258B1 (pl) 1998-02-27
NO302616B1 (no) 1998-03-30
CZ294257B6 (cs) 2004-11-10
RU94039539A (ru) 1997-05-27
WO1993016037A1 (en) 1993-08-19
IL104484A0 (en) 1993-05-13
EP0625967B1 (en) 1997-08-27
DK0625967T3 (da) 1998-03-23
IL104484A (en) 1998-07-15
NO942988L (no) 1994-10-05
EP0625967A1 (en) 1994-11-30
DE69313438T2 (de) 1998-03-19
NO942988D0 (no) 1994-08-12
AU3475993A (en) 1993-09-03
FI943738A (fi) 1994-10-12
GR3025429T3 (en) 1998-02-27
CN1057520C (zh) 2000-10-18
HU9401976D0 (en) 1994-09-28
AU668709B2 (en) 1996-05-16
RU2133737C1 (ru) 1999-07-27
OA10094A (en) 1996-12-18

Similar Documents

Publication Publication Date Title
EG20476A (en) Process for preparing of n,n'- substituted imidodicarboninidic diamides derived from hydroxylamines
RO112619B1 (ro) Derivaţi de fluorcitidină, procedeu pentru obţinerea acestora şi compoziţie farmaceutică ce conţine aceşti derivaţi
ES8500902A1 (es) Un procedimiento para la preparacion de un derivado del indol.
ATE165810T1 (de) N-substituierte derivate des n-methyl-3-(p- trifluormethylphenoxy)-3-phenylpropylamins und verfahren zu deren herstellung
DK0548338T3 (da) Fremgangsmåde til fremstilling af cephalosporinmellemprodukter
CS185091A3 (en) Novel n-benzyl-n'-phenyl and phenylalkyl-thioureas
ZA946659B (en) 2(1h)-quinolone compounds process for preparing them and pharmaceutical compositions containing them
PT1021405E (pt) Derivados de azetidinona para o tratamento de infeccoes de hcmv
ATE75472T1 (de) Ergolinylheterocyclen.
ES8703457A1 (es) Un procedimiento para la preparacion de nuevos derivados de tiacetona.
CA2036643A1 (en) Sulfur-containing esters as synergists of amine and phenolic antioxidants
FR2794122B1 (fr) Nouveaux antioxydants, procedes de preparation et utilisations